Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 28, Issue 4 (July 2026) 28, 398–408; 10.4103/aja2025108

C-phycocyanin protects against obesity-associated type 2 diabetes-induced male fertility dysfunction via key enzyme regulation

AlRashidi, Aljazi Abdullah1; Rajeh, Sahar Y1; Hamden, Khaled2,3

1Department of Chemistry, College of Science, University of Ha’il, Ha’il 81451, Saudi Arabia

2Laboratory of Bioresources Integrative Biology and Exploiting, Higher Institute of Biotechnology of Monastir, University of Monastir, Monastir 5000, Tunisia

3Higher School of Health Sciences and Technology of Sfax, Sfax University, Sfax 3000, Tunisia.

Correspondence: Dr. K Hamden (khaled.hamden@issatmh.rnu.tn)

Received: 13 September 2025; Accepted: 26 November 2025; published online: 24 February 2026

Abstract

The prevalence of male infertility is steadily increasing and has become a growing global health concern. The goal of this study is to evaluate the therapeutic potential of C-phycocyanin (CPC), a natural phycobiliprotein pigment extracted from Spirulina platensis (Sp), on male reproductive dysfunction in obese rats with type 2 diabetes (OB-T2D). Daily treatment was administered for 3 months. CPC at 300 mg kg−1 significantly reduced body weight (−35.6%) and blood glucose levels (−40.2%). It markedly suppressed seminal plasma inflammation by reducing leukocyte count and the activities of myeloperoxidase (MPO), phospholipase A2 (PLA2), and elastase (ELA) in seminal plasma by 77.3%, 63.1%, and 55.4%, respectively. CPC significantly improved sperm quality by increasing sperm concentration as well as the percentages of sperm viability and motility, while significantly reducing the percentage of sperm abnormalities. In parallel, CPC stimulated key fertility-related enzymes, including 3β-hydroxysteroid dehydrogenase (3β-HSD), 17β-hydroxysteroid dehydrogenase (17β-HSD), adenosine triphosphatase (ATPase), prostatic acid phosphatase (PAP), lactate dehydrogenase (LDH), and adenosine deaminase (ADA), while downregulating phosphodiesterase (PDE). Moreover, CPC optimized seminal plasma composition by increasing fructose levels, modulating pH, and enhancing the activity of hyaluronidase (HYAL) and alkaline phosphatase (ALP). Seminal plasma antioxidant defense was strengthened via increased activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione S-transferase (GST); and reduced oxidative stress markers including total oxidant status (TOS), hydrogen peroxide (H2O2), and thiobarbituric acid reactive substances (TBARS). Therefore, CPC exerts a potent protective effect against OB-T2D-induced reproductive dysfunction by improving sperm parameters, enzymatic activity, and seminal antioxidant capacity.

Keywords: antioxidant; C-phycocyanin; enzyme; inflammation; obesity; sperm

Full Text | PDF |

 
Browse:  2
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.